Annual Sickle Cell Disease and Thalassaemia Conference (ASCAT) 2019

 

 

The Annual Scientific Conference on Sickle Cell and Thalassaemia is one of the must attend events of the year for consultants and specialist psychologists, nurses, scientists and all relevant experts. The event is an ideal opportunity to see the latest advances in diagnosis, treatment and emerging fields in haemoglobinopathies. It is an opportunity to interact on the latest advances in clinical care, transition services and emerging new therapies including updates for curative treatment options. Furthermore, you will have the opportunity to show case your work through abstracts (oral and posters) and to network with leading and cutting edge practitioners.

Event Date:     21 Oct 2019 – 23 Oct 2019

Time:              8.30am  – 16.30pm

Location:         Westminster Bridge, County Hall, Belvedere Rd, London, SE1 7PB

This year’s theme is ‘Sickle cell and Thalassaemia disorders new treatment horizon; while ensuring patient safety and delivering excellence in routine patient care’; seeking to build on the previous meetings themes and address some of the areas that delegates suggest further coverage. With the emergence of new therapies in the horizon and the complexities in decision making, challenges in funding; new strategies are required to ensure the sustainable programme. This is relevant in all settings including developed countries where disparities still exist and professional and user engagement is limited.

In 2019 we plan to address a wide variety of topics including:

  • Implementation of Newborn Screening for hemoglobinopathies, cohort’s studies, and the development of management protocols and national control programmes.
  • New therapies including clinical trials at different stages- Phase I/II/III in sickle cell disease and thalassaemia
  • Update on Gene therapies, gene editing and bone marrow transplantation
  • Psychosocial aspects including body, mind and health related quality of life in sickle cell disease and thalassaemia
  • Blood transfusion including apheresis, iron chelation therapy and acute haemolytic complications.
  • Quality standards in the diagnosis, treatment of sickle cell and thalassaemia- Global priorities
  • ‘Meet the expert’ sessions, seminars and tutorials.
  • A full patient forum to involve children and adults and parents experience will be shared during the three days.

Highlights to include prizes for the highest ranked abstract and poster presentations. Abstracts are now open, closes 15th August 2019, entry forms/details below.

More info & book your place

error: Content is protected !!
0

UK Forum 48th Academic Meeting 8th May 2019        Information & Registration

¤